Nelvir Tablet Bangladeshi - Kiingereza - DGDA (Directorate General of Drug Administration)

nelvir tablet

square pharmaceuticals plc, pabna - nelfinavir - tablet - 250 mg

SEDACID 10 MG GASTRO-RESISTANT TABLETS Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sedacid 10 mg gastro-resistant tablets

pinewood laboratories ltd, - omeprazole ph. eur. - tablets gastro-resistant - 10 milligram

SEDACID 20 MG GASTRO-RESISTANT TABLETS Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sedacid 20 mg gastro-resistant tablets

pinewood laboratories ltd, - omeprazole ph. eur. - tablets gastro-resistant - 20 milligram

GLIVEC  100 MG Israeli - Kiingereza - Ministry of Health

glivec 100 mg

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).glivec is also indicated for the treament of : * adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy.* adult patients with relapsed or refractory ph + all as monotherapy.* adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. * adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet - derived growth factor receptor ) gene re- arrangements. * adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative. * adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.* adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.